Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas

Oliver, Matthew J.; McCann, Richard L.; Indridason, Ólafur S.; Butterly, David W.; Schwab, Steve J.

doi:10.1046/j.1523-1755.2001.00956.x

Cited by 202 publications

(223 citation statements)

References 13 publications

Supporting

Mentioning

193

Contrasting

Unclassified

Order By: Relevance

“…Fistulas that fail to mature (FTM) are increasingly more common with rates between 9% and 70% (18,19) and the highest FTM rates among the elderly, diabetics, and those with vascular disease (19), the same group that represents the largest growth in dialysis. When this early fistula failure is considered in cumulative patency analysis, there is little difference compared with graft patency (20,21). The role of a graft needs to be reconsidered given the conquerable patency and the trade off between interventions required to get a fistula to maturation versus intervention to maintain patency in a graft (22), and the shortened time from creation to use.…”

Section: Discussionmentioning

confidence: 99%

Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk

Moist

Trpeski

et al. 2008

Clinical Journal of the American Society of Nephrology

136

117

View full text Add to dashboard Cite

.6% to 18.6%, and grafts remained between 2.1% to 2.6%. Prevalent catheter use increased from 41.8% to 51.7%, and fistulas and grafts decreased from 46.8% to 41.6% and 11.4% to 6.7%, respectively. There was significant variation in incident and prevalent fistulae use among the provinces. Adjustment for differences in patient characteristics did not change these trends. Incident catheter use was associated with a 6 times greater risk of death compared with fistula or graft use combined.Conclusions: In Canada there has been a decrease in fistulae and grafts with a subsequent increase in catheters that is not explained by changes in patient characteristics. Vascular access use varied by province, suggesting differences in practice patterns. Because incident catheter use was associated with increased mortality, urgent measures are needed to develop strategies to decrease catheter use.

show abstract

Section: Discussionmentioning

confidence: 99%

Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk

Moist

Trpeski

et al. 2008

Clinical Journal of the American Society of Nephrology

136

117

View full text Add to dashboard Cite

show abstract

“…Indeed, altering the presentation of data comparing cumulative survival (time from access creation to irreversible failure) can have a significant impact on the conclusion that survival of AVF is superior to grafts. One-year primary (intervention-free or unassisted) survival ( Figure 6) and secondary (cumulative or assisted) survival are higher in AVF than in grafts when early failures or failures of AVF maturation are excluded, but this is not true for cumulative patency when early events are included in the analysis (20,70). Allon et al (20) found a superior 6-mo assisted patency rate with grafts and an identical 2-yr cumulative patency when compared with AVF.…”

Section: Impact On the Patient: The Patient Is Firstmentioning

confidence: 99%

Fistula First Initiative

Lok¹

2007

Clinical Journal of the American Society of Nephrology

279

231

View full text Add to dashboard Cite

“…Patients were followed up for 1 yr, during which primary and secondary AVF patency rates were measured. T he low prevalence of the arteriovenous fistula (AVF) among US hemodialysis (HD) patients (1,2) has initiated nationwide measures to increase AVF creation and prevalence (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). Among these are providing educational programs, setting forth guidelines and goals (3,4), implementing multidisciplinary approaches (4 -9), encouraging preoperative venous mapping (14 -19), and asking surgeons to create AVF instead of arteriovenous grafts (AVG) (10 -21).…”

mentioning

confidence: 99%

Endovascular Treatment of the “Failing to Mature” Arteriovenous Fistula

Nassar

Nguyen

Rhee

et al. 2006

Clinical Journal of the American Society of Nephrology

148

100

View full text Add to dashboard Cite

In recent literature, surgically created hemodialysis (HD) arteriovenous fistulas (AVF) have high rates of primary failure. Endovascular treatment holds promise to salvage these fistulae. The outcomes of 119 patients who had a "failing to mature" AVF and presented for endovascular management were evaluated prospectively. All patients underwent a fistulogram. Stenotic lesions underwent balloon angioplasty, and accessory veins underwent obliteration. Technical success was determined immediately after the procedure. AVF salvage was determined by successful use during HD. Patients were followed up for 1 yr, during which primary and secondary AVF patency rates were measured. T he low prevalence of the arteriovenous fistula (AVF) among US hemodialysis (HD) patients (1,2) has initiated nationwide measures to increase AVF creation and prevalence (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). Among these are providing educational programs, setting forth guidelines and goals (3,4), implementing multidisciplinary approaches (4 -9), encouraging preoperative venous mapping (14 -19), and asking surgeons to create AVF instead of arteriovenous grafts (AVG) (10 -21).Overall, an increase in AVF prevalence is occurring in the United States, albeit at a slow rate (14 -20). One impediment has been high primary failure rates, which in recent series ranged between 23 and 46% (9,(12)(13)(14). The use of ultrasound or other means of preoperative venous mapping is likely to decrease the incidence of primary AVF failures (14 -19). However, the increasing demand to create more fistulas may lead to their creation in borderline vessels, thereby increasing primary failure rates (21-23). Thus, salvage of these primary failures will be essential for increasing AVF prevalence in the United States.In our dedicated endovascular suite, we used percutaneous angioplasty and accessory vein obliteration in attempts to salvage fistulas with primary failure. Because most did not present with thrombosis, we elected to refer to their fistulas as "failing to mature." In this article, we report our initial success rates as well as follow-up on a series of 119 consecutive patients who were referred for salvage of their "failing to mature" AVF. Materials and Methods DefinitionsThe "failing to mature" AVF in our series was defined as an AVF that had been created for at least 8 wk but had not matured enough to allow successful cannulation or use during HD. This includes (1) fistulas that were never cannulated for HD be cause of obvious lack of maturity; (2) fistulas that failed first cannulation attempts and were abandoned; (3) fistulas that were cannulated successfully but could not be used because the blood flow was insufficient to sustain HD; this may have been because of high venous pressure or poor arterial inflow; and (4) fistulas that thrombosed before any attempts at HD. Juxta-arterial anastomosis segment refers to the initial 5 cm of the AVF starting at the arterial anastomosis. Peripheral vein refers to the venous outflow tract of t...

show abstract

Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas

Cited by 202 publications

References 13 publications

Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk

Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk

Fistula First Initiative

Endovascular Treatment of the “Failing to Mature” Arteriovenous Fistula

Contact Info

Product

Resources

About